American Vanguard (AVD)
(Delayed Data from NYSE)
$6.31 USD
+0.05 (0.80%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $6.32 +0.01 (0.16%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.31 USD
+0.05 (0.80%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $6.32 +0.01 (0.16%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum F VGM
Zacks News
American Vanguard (AVD) Q1 Earnings Beat, Sales Lag Estimates
by Zacks Equity Research
American Vanguard (AVD) witnesses strong sales gains in international business in Q1.
New Strong Sell Stocks for May 8th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
American Vanguard (AVD) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
American Vanguard (AVD) delivered earnings and revenue surprises of 8.33% and -2.71%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for May 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Kraton (KRA) to Construct Semi Works Latex Unit in Brazil
by Zacks Equity Research
Kraton's (KRA) Cariflex technology has high growth potential. The platform will boost the company's ability to capitalize on key market opportunities.
American Vanguard (AVD) Q4 Earnings Top, Sales Lag Estimates
by Anindya Barman
Acquisitions drove American Vanguard's (AVD) revenues in 2018. The company expects its global revenues to exceed $500 million in 2019.
American Vanguard (AVD) Upgraded to Buy: Here's Why
by Zacks Equity Research
American Vanguard (AVD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chemicals Start 2019 on Soft Note With Tepid January Growth
by Anindya Barman
Trade tensions between the United States and China have clouded the prospects of the chemical industry.
American Vanguard Takes Over Agrovant & Defensive in Brazil
by Zacks Equity Research
The acquisitions help American Vanguard (AVD) expand access to the Brazilian agricultural sector.
American Vanguard Buys QPE Herbicides Products from Corteva
by Zacks Equity Research
QPE product line buyout provides American Vanguard's (AVD) crop protection business with a portfolio of herbicide brands that holds vital leadership positions in the North American market.
Zacks.com featured highlights include: Global Net, CECO, American Vanguard and Fidelity Southern
by Zacks Equity Research
Zacks.com featured highlights include: Global Net, CECO, American Vanguard and Fidelity Southern
4 Stocks to Keep an Eye On as Analysts Initiate Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
American Vanguard (AVD) Q3 Earnings Top, Sales Trail Estimates
by Anindya Barman
American Vanguard (AVD) sees strong sales from its soil fumigants and Equus fungicide in Q4.
American Vanguard (AVD) Beats Q3 Earnings Estimates
by Zacks Equity Research
American Vanguard (AVD) delivered earnings and revenue surprises of 4.76% and -5.11%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
American Vanguard (AVD) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
American Vanguard (AVD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemical - Specialty Outlook: Trade Tensions Cloud Prospects
by Zacks Equity Research
The chemical specialty industry is bearing the brunt of trade tensions between Washington and Beijing.
New Strong Sell Stocks for September 19th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for August 21st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for August 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
American Vanguard (AVD) Q2 Earnings Top, Sales Miss Estimates
by Anindya Barman
American Vanguard (AVD) sees strong performance across a number of major components of its business through the remainder of 2018.
American Vanguard (AVD) Q2 Earnings Beat Estimates
by Zacks Equity Research
American Vanguard (AVD) delivered earnings and revenue surprises of 11.76% and -5.60%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates
by Zacks Equity Research
American Vanguard's (AVD) Q1 results benefit from 2017 product and company acquisitions, along with its diversified presence in many markets.
New Strong Sell Stocks for April 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for April 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: